nicotine has been researched along with atorvastatin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Cai, JQ; Cao, XZ; Luo, ZR; Zhang, HM | 1 |
| Das S, S; Febi, J; Indira, M; Kavitha, S; Nair, SS | 1 |
| Indira, M; Nair, SS; Syam Das, S | 1 |
1 trial(s) available for nicotine and atorvastatin
| Article | Year |
|---|---|
Effect of atorvastatin on vascular endothelial function in moderately nicotine-dependent smokers.
Topics: Adult; Atorvastatin; Cholesterol, LDL; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Lipids; Lipoproteins, HDL; Male; Middle Aged; Nicotine; Pyrroles; Tobacco Use Disorder; Triglycerides; Vasodilation | 2014 |
6 other study(ies) available for nicotine and atorvastatin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Atorvastatin improves Y-maze learning behaviour in nicotine treated male albino rats.
Topics: Adenosine Triphosphatases; Animals; Atorvastatin; Brain; Discrimination Learning; Dose-Response Relationship, Drug; Glutathione; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Male; Maze Learning; Monoamine Oxidase; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Serotonin | 2015 |
Atorvastatin modulates drug transporters and ameliorates nicotine-induced testicular toxicity.
Topics: Animals; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; Blood-Testis Barrier; Catecholamine Plasma Membrane Transport Proteins; Male; Nicotine; Rats; Rats, Sprague-Dawley; Solute Carrier Proteins; Testis | 2018 |